Wearable watch for monitoring leptomeningeal metastasis
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether wearing a smartwatch can help monitor your symptoms and get you help faster if you have cancer that has spread to the lining of your brain and spinal cord. You'll wear the watch and use a phone app to track how you're feeling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer that has spread to the lining of your brain and spinal cord (called leptomeningeal metastasis).
- You are currently getting cancer treatment (like chemotherapy, radiation, or spinal injections) or being closely watched.
- You are 18 years or older.
- You are able to take care of yourself and do daily activities (Karnofsky score of 50 or higher).
- You have a compatible smartphone (iPhone with iOS 16 or higher, or an Android phone that works with the study app) and are willing to wear a smartwatch for at least 10 hours a day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a smartwatch to monitor your activity and recovery after treatment for sarcoma or bone cancer in your leg or pelvis. It helps your care team keep track of how you're doing from home.
This study tests whether patients in early-phase cancer trials can comfortably use smartwatches and phone apps to track their health and report how they're feeling. The goal is to see if these tools can help doctors better understand how cancer treatments affect daily life.
This study tests whether wearing a smartwatch and using an app can help doctors better manage pain and other symptoms in advanced cancer patients. The goal is to catch problems early and improve comfort through better symptom tracking.
This study tests whether using a wearable watch and smartphone app to track activity and fitness can help monitor health in people with hormone receptor–positive, HER2-negative metastatic breast cancer while they take standard hormone therapy plus palbociclib. It mainly requires that you are already on these medicines for at least three months and can use the devices reliably.
This trial uses an Apple Watch and a smartphone app to track health data and detect early signs of infection in children and teens getting cancer treatment. The goal is to catch problems early so they can be treated quickly.
This study tests whether people treated for brain tumors can safely use a tailored exercise program tracked by a smartwatch. The goal is to see if gentle, adapted physical activity helps manage side effects like weakness, memory problems, or concentration difficulties.
Hear when a new Leptomeningeal Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.